The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Osilodrostat, an oral cortisol synthesis inhibitor, was previously approved for treating adults with Cushing disease, a subtype of Cushing syndrome in which the hypercortisolemia is due to pituitary ...

The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option ...

New research has increased knowledge about how best to manage equines with Cushing’s syndrome — for which the correct veterinarty term is Pituitary Pars Intermedia Dysfunction (PPID) — one of the most ...

Cushing’s syndrome survivor and public health advocate ... We need government support in research, advocacy, and treatment,” she said. Her mother, Safiya Abubakar Koko, also spoke at the ...

Once a patient is diagnosed with Cushing syndrome, it's important to see a specialist for further guidance and treatment, says Grossman. Treatment will depend on whether the problem is in the ...

Asignificant advancement in medical imaging has been achieved by experts at the Postgraduate Institute of Medical Education and Research. Researchers from endocrinology and nuclear medicine ...